3rd Annual Compliance Online Medical Device Summit
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

3rd Annual ComplianceOnline Medical Device Summit 2017
Event Date: 08 June, 2017 13:00   Venue : Boston, MA

  • Summary
  • Agenda
ComplianceOnline is hosting an event 3rd Annual Medical Device Summit 2017, which will be held from June 8-9, 2017 at the Boston, MA.

This Summit will feature speakers and panelists from CDRH/OC at FDA, CDRH/FDA and companies like Johnson & Johnson, Baxter, Janssen Pharmaceuticals, Starfish Medicals, Point Care Technology, Boston Scientific and several other leading organizations. You can view the latest event agenda and speaker lineup from past summits here: 3rd Annual Medical Device Summit 2017.

Register Now for the 3rd Annual Medical Device Summit 2017 at a discounted rate of $999 (discounted from of $1699). Early Bird pricing saves you $700 off the standard registration rate when booking before February 25, 2017. To register, please click HERE or call +1-888-717-2436.

  • Growth & Opportunities 2020: Vision 2020 & Beyond
  • FDA Enforcement - Outlook & Implications
  • CDRH 2017-2017 Priorities
  • 3-D Printed Medical Devices - Next?
  • Data Integrity Program
  • Digital Health and Medical Devices
  • Medical Device Cyber Security
  • Medical Device Recall and Complaint Management
  • Risk Management for Medical Devices

Check for more details:- http://bit.do/iarcevent-35

This presentation addresses the challenges of bringing new medical device technologies to market in the context of market trends that seem to circumvent regulatory requirements. There is a need to balance market opportunity – such as wearable devices that provide useful diagnostic data – with the need to assure safe and effective adoption of those devices. Specific examples of new technologies are presented that appear to avoid standard compliance requirements under the disclaimer that they are “not a medical device”. The presentation addresses the issue of how users (i.e., patients) can adopt these devices, how clinicians can use the data in patient treatment, and how regulatory oversight could address the gap between device use and safety.